Evidence lags behind excitement over blood plasma as a coronavirus treatment

Researchers call for more rigorous clinical trials as rumours abound that US regulators are considering widening access to the potential therapy. Researchers call for more rigorous clinical trials as rumours swirl that US regulators might authorize the potential therapy.